NCT03981887View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous Nafithromycin

PHASE1CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

June 18, 2019

Primary Completion Date

July 2, 2019

Study Completion Date

August 7, 2019

Conditions

Healthy

Interventions

DRUG

Nafithromycin

Nafithromycin 200 mg as IV infusion

OTHER

Placebo

placebo administered as IV infusion

Trial Locations (1)

53095

Spaulding Clinical Research, West Bend

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Clinartis, LLC

UNKNOWN

collaborator

Keystone Bioanalytical, Inc.

UNKNOWN

lead

Wockhardt

INDUSTRY